Swedish Orphan Biovitrum Toekomstige groei
Future criteriumcontroles 4/6
Swedish Orphan Biovitrum zal naar verwachting groeien in winst en omzet met respectievelijk 20.2% en 9% per jaar. De winst per aandeel zal naar verwachting groeien met 20.8% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 12.8% zijn.
Belangrijke informatie
20.2%
Groei van de winst
20.8%
Groei van de winst per aandeel
Biotechs winstgroei | 45.7% |
Inkomstengroei | 9.0% |
Toekomstig rendement op eigen vermogen | 12.8% |
Dekking van analisten | Good |
Laatst bijgewerkt | 22 Nov 2024 |
Recente toekomstige groei-updates
Swedish Orphan Biovitrum AB (publ) Just Beat EPS By 95%: Here's What Analysts Think Will Happen Next
Oct 27Earnings Beat: Swedish Orphan Biovitrum AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jul 19Recent updates
Swedish Orphan Biovitrum AB (publ) Just Beat EPS By 95%: Here's What Analysts Think Will Happen Next
Oct 27Earnings Beat: Swedish Orphan Biovitrum AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jul 19Swedish Orphan Biovitrum (STO:SOBI) Seems To Use Debt Quite Sensibly
Jun 24Here's Why Shareholders May Consider Paying Swedish Orphan Biovitrum AB (publ)'s (STO:SOBI) CEO A Little More
May 08Swedish Orphan Biovitrum AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Apr 27Investors Still Waiting For A Pull Back In Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Apr 24Swedish Orphan Biovitrum AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 06Swedish Orphan Biovitrum (STO:SOBI) Seems To Use Debt Quite Sensibly
Mar 05Swedish Orphan Biovitrum's (STO:SOBI) Weak Earnings May Only Reveal A Part Of The Whole Picture
Feb 15Swedish Orphan Biovitrum AB (publ)'s (STO:SOBI) Earnings Haven't Escaped The Attention Of Investors
Jan 17Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Nov 24Is Swedish Orphan Biovitrum (STO:SOBI) Using Too Much Debt?
Jul 07Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Apr 02Is Swedish Orphan Biovitrum AB (publ) (STO:SOBI) Trading At A 30% Discount?
Jan 11These 4 Measures Indicate That Swedish Orphan Biovitrum (STO:SOBI) Is Using Debt Reasonably Well
Dec 27Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Sep 28Is Swedish Orphan Biovitrum (STO:SOBI) Using Too Much Debt?
Jun 26Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 31,331 | 6,487 | 9,118 | 9,553 | 11 |
12/31/2025 | 27,856 | 4,841 | 7,306 | 7,853 | 11 |
12/31/2024 | 25,410 | 3,489 | 5,945 | 5,924 | 11 |
9/30/2024 | 25,435 | 3,514 | 3,255 | 6,663 | N/A |
6/30/2024 | 23,710 | 2,145 | 5,056 | 6,716 | N/A |
3/31/2024 | 23,140 | 2,142 | 2,313 | 4,743 | N/A |
12/31/2023 | 22,123 | 2,409 | -473 | 4,470 | N/A |
9/30/2023 | 21,270 | 2,769 | 743 | 5,291 | N/A |
6/30/2023 | 20,100 | 3,125 | 120 | 4,977 | N/A |
3/31/2023 | 19,104 | 3,162 | 337 | 4,915 | N/A |
12/31/2022 | 18,790 | 2,638 | 3,099 | 4,576 | N/A |
9/30/2022 | 17,696 | 2,493 | 3,145 | 4,804 | N/A |
6/30/2022 | 17,458 | 2,516 | 3,363 | 4,317 | N/A |
3/31/2022 | 16,793 | 2,526 | 4,979 | 5,415 | N/A |
12/31/2021 | 15,529 | 2,679 | 5,100 | 5,470 | N/A |
9/30/2021 | 15,214 | 2,940 | 1,405 | 4,066 | N/A |
6/30/2021 | 14,424 | 2,744 | 378 | 4,190 | N/A |
3/31/2021 | 14,283 | 2,759 | 819 | 4,739 | N/A |
12/31/2020 | 15,261 | 3,245 | 1,074 | 4,926 | N/A |
9/30/2020 | 15,570 | 3,103 | 3,101 | 5,185 | N/A |
6/30/2020 | 15,530 | 3,367 | 5,747 | 5,799 | N/A |
3/31/2020 | 15,622 | 3,583 | 5,176 | 5,132 | N/A |
12/31/2019 | 14,248 | 3,304 | -5,171 | 3,634 | N/A |
9/30/2019 | 11,929 | 2,539 | -4,868 | 3,195 | N/A |
6/30/2019 | 11,313 | 2,620 | -6,526 | 2,912 | N/A |
3/31/2019 | 10,440 | 2,806 | -7,233 | 2,201 | N/A |
12/31/2018 | 9,139 | 2,418 | 1,512 | 2,090 | N/A |
9/30/2018 | 8,443 | 2,181 | 1,217 | 1,810 | N/A |
6/30/2018 | 7,729 | 1,881 | N/A | 1,678 | N/A |
3/31/2018 | 7,079 | 1,462 | N/A | 1,287 | N/A |
12/31/2017 | 6,511 | 1,149 | N/A | 1,333 | N/A |
9/30/2017 | 5,927 | 865 | N/A | 1,103 | N/A |
6/30/2017 | 5,497 | 677 | N/A | 604 | N/A |
3/31/2017 | 5,327 | 703 | N/A | 431 | N/A |
12/31/2016 | 5,204 | 802 | N/A | 343 | N/A |
9/30/2016 | 4,727 | 716 | N/A | 329 | N/A |
6/30/2016 | 4,341 | 585 | N/A | 493 | N/A |
3/31/2016 | 3,636 | 291 | N/A | 573 | N/A |
12/31/2015 | 3,228 | 65 | N/A | 507 | N/A |
9/30/2015 | 3,119 | 59 | N/A | 547 | N/A |
6/30/2015 | 3,000 | 108 | N/A | 426 | N/A |
3/31/2015 | 2,899 | 136 | N/A | 268 | N/A |
12/31/2014 | 2,607 | -268 | N/A | 234 | N/A |
9/30/2014 | 2,513 | -263 | N/A | 185 | N/A |
6/30/2014 | 2,364 | -373 | N/A | 86 | N/A |
3/31/2014 | 2,221 | -410 | N/A | 189 | N/A |
12/31/2013 | 2,177 | -93 | N/A | 185 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei SOBI ( 20.2% per jaar) ligt boven de spaarquote ( 1.2% ).
Winst versus markt: De winst van SOBI ( 20.2% per jaar) zal naar verwachting sneller groeien dan de Swedish markt ( 15% per jaar).
Hoge groeiwinsten: De winst van SOBI zal naar verwachting de komende 3 jaar aanzienlijk groeien.
Omzet versus markt: De omzet van SOBI ( 9% per jaar) zal naar verwachting sneller groeien dan de markt Swedish ( -0% per jaar).
Hoge groei-inkomsten: De omzet van SOBI ( 9% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen SOBI zal naar verwachting over 3 jaar laag zijn ( 12.8 %).